Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.004 |